|
Demographics |
|||
| ST cases |
Individual Controls |
p value |
|
|
|
|||
| Age |
61.9 ± 5.7 |
61.8 ± 4.3 |
N/S |
| Sex (% Male) |
86 |
86 |
N/S |
| Smokers (%) |
42.9 |
35.7 |
N/S |
| Diabetes (%) |
14.3 |
14.3 |
N/S |
| Emergency cases (%) |
14.3 |
14.3 |
N/S |
| Elective cases (%) |
14.3 |
33.3 |
N/S |
| ACS cases (%) |
71.4 |
52.4 |
N/S |
| Stent length (mm) |
26.7 ± 11.3 |
27.9 ± 6.3 |
N/S |
| Minimum stent diameter (mm) |
2.8 ± 0.3 |
2.9 ± 0.3 |
N/S |
| Aspirin dose (mg) |
140 ± 21.0 |
140 ± 13.4 |
N/S |
| Clopidogrel dose (mg) |
86 ± 21 |
75 |
N/S |
| Duration of clopidogrel (days) |
161 ± 163 |
77 ± 28 |
N/S |
| Time from latest event/intervention (days) |
145 ± 84 |
76 ± 28 |
N/S |
| Statin (% total/% Atorvastatin) |
100/14 |
100/7 |
N/S |
|
Summary of demographics in the seven cases and 14 controls. There are no significant differences between the groups. | |||
Hobson et al. Thrombosis Journal 2008 6:1 doi:10.1186/1477-9560-6-1 |
|||